搜尋結果
A Deeper Look at Anti-PD-1/PD-L1 Checkpoint Inhibitors for Cancer
Forbes· 1 日前In a previous story, I described pembrolizumab, a PD-1 targeting checkpoint inhibitor, in some ...
Gilead's Trodelvy fails to meet main goal in late-stage cancer study
Reuters· 1 日前, opens new tab said on Thursday its drug Trodelvy, tested in patients with bladder cancer who ...